LENZ Therapeutics, Inc. (GRPH) Operating Lease, Right-of-Use Asset USD 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LENZ Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2021 to 2024.
  • LENZ Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $578 K, a 85.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $578 K -$3.44 M -85.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $318 K -$5.26 M -94.3% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $13.2 M +$6.08 M +85.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $15.8 M +$7.2 M +83.4% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $4.01 M -$6.11 M -60.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.58 M -$5.99 M -51.8% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $7.12 M -$1.96 M -21.6% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $8.64 M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $10.1 M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $11.6 M Dec 31, 2021 10-K 2023-03-20
Q3 2021 $9.08 M Sep 30, 2021 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.